RCUK Shared Services Centre Ltd extends contract with Cambridge Research Biochemicals
Cambridge Research Biochemicals Signs Exclusive Japanese Distribution Deal with BioBridge
UCB and Domainex collaboration provides valuable information on cancer drug target using CDH technology.
Xceleron Announces New Investment And Move To Purpose-Built Laboratories In U.S. Demand in translational science drives need for additional equipment
Cambridge Research Biochemicals signs agreement with Life Technologies to offer custom dye labelled antibodies.
Domainex Awarded Technology Strategy Board Funding to Support its Research into a Novel Cancer Drug
